Periprocedural reversal and bridging of anticoagulant treatment

Netherlands Journal of Medicine

Volumn 69, Issue 6, 2011, Pages 268-273

  Levi, M ^a   Eerenberg, E ^a   Kamphuisen, P W ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Anticoagulants; Aspirin; Bridging; Clopidogrel; Hemorrhage; Heparin; Prasugrel; Surgery; Vitamin K antagonists

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CLOPIDOGREL; DESMOPRESSIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENPROCOUMON; PLACEBO; PRASUGREL; VITAMIN K GROUP; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HUMAN; PERIOPERATIVE PERIOD; REVIEW; RISK FACTOR; SCORING SYSTEM; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD COAGULATION; HEMORRHAGE; HUMANS; ORGANIC CHEMICALS; PERIOPERATIVE CARE; PERIOPERATIVE PERIOD; RISK ASSESSMENT; SURGICAL PROCEDURES, OPERATIVE; THROMBOEMBOLISM;

EID: 80051746563     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Hirsh J, Guyatt G, Albers GW, Harrington R, Schunemann HJ. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):110S-112S.
2. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356(22):2301-11.
3. Levi M. Emergency reversal of antithrombotic treatment. Intern Emerg Med. 2009;4(2):137-45.
4. Levi MM, Eerenberg E, Lowenberg E, Kamphuisen PW. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management. Neth J Med. 2010;68(2):68-76.
5. Levi M, Hobbs FD, Jacobson AK, et al. Improving antithrombotic management in patients with atrial fibrillation: current status and perspectives. Semin Thromb Hemost. 2009;35(6):527-42.
6. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002;347(23):1834-40.
7. Vink R, Rienstra M, Van Dongen CJ, et al. The risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation. Am J Cardiol. 2005; September 15;96(6):822-4.
8. Douketis JD, Crowther MA, Cherian SS. Perioperative anticoagulation in patients with chronic atrial fibrillation who are undergoing elective surgery: results of a physician survey. Can J Cardiol. 2000;16(3):326-30.
9. Douketis JD, Berger PB, Dunn AS, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):299S-339S.
10. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):257S-298S.
11. Saour JN, Sieck JO, Mamo LA, Gallus AS. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med. 1990;322(7):428-32.
12. Hutten BA, Lensing AW, Kraaijenhagen RA, Prins MH. Safety of treatment with oral anticoagulants in the elderly. A systematic review. Drugs Aging. 1999;14(4):303-12.
13. Fang MC, Chang Y, Hylek EM, et al. Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med. 2004;141(10):745-52.
14. Levi M, Hovingh GK, Cannegieter SC, Vermeulen M, Buller HR, Rosendaal FR. Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based. Blood. 2008;111(9):4471-6.
15. Hart RG, Benavente O, Pearce LA. Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: A meta-analysis and hypothesis. Cerebrovasc Dis. 1999;9(4):215-7.
16. Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR. Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit. Ann Intern Med. 2005;143(4):241-50.
17. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):160S-198S.
18. Dentali F, Ageno W, Crowther M. Treatment of coumarin-associated coagulopathy: a systematic review and proposed treatment algorithms. J Thromb Haemost. 2006;4(9):1853-63.
19. Crowther MA, Ageno W, Garcia D, et al. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin. Ann Intern Med. 2009;150:293-300.
20. Crowther MA, Douketis JD, Schnurr T, et al. Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy. A randomized, controlled trial. Ann Intern Med. 2002;137(4):251-4.
21. Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D. Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study. Arch Intern Med. 2003;163(20):2469-73.
22. van Geest-Daalderop JH, Hutten BA, Pequeriaux NC, de Vries-Goldschmeding HJ, Rakers E, Levi M. Invasive procedures in the outpatient setting: Managing the short-acting acenocoumarol and the long-acting phenprocoumon. Thromb Haemost. 2007;98(4):747-55.
23. Dentali F, Ageno W. Management of coumarin-associated coagulopathy in the non-bleeding patient: a systematic review. Haematologica. 2004;89(7):857-62.
24. Aguilar MI, Hart RG, Kase CS, et al. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion. Mayo Clin Proc. 2007;82(1):82-92.
25. van Aart L, Eijkhout HW, Kamphuis JS, et al. Individualized dosing regimen for prothrombin complex concentrate more effective than standard treatment in the reversal of oral anticoagulant therapy: an open, prospective randomized controlled trial. Thromb Res. 2006;118(3):313-20.
26. Kessler CM. Urgent reversal of warfarin with prothrombin complex concentrate: where are the evidence-based data? J Thromb Haemost. 2006;4(5):963-6.
27. Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, Ostermann H. Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost. 2008;6(4):622-31.
28. Levi M. Disseminated intravascular coagulation. Crit Care Med. 2007;35:2191-5.
29. Merritt JC, Bhatt DL. The efficacy and safety of perioperative antiplatelet therapy. J Thromb Thrombolysis. 2004;17(1):21-7.
30. Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. 1985;103(2):228-39.
31. Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med. 2007;356:2301-11.
32. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345(7):494-502.
33. Bhatt DL. Prasugrel in clinical practice. N Engl J Med. 2009;361(10):940-2.
34. Grines CL, Bonow RO, Casey DE Jr, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Catheter Cardiovasc Interv. 2007;69(3):334-40.
35. Vilahur G, Choi BG, Zafar MU, et al. Normalization of platelet reactivity in clopidogrel-treated subjects. J Thromb Haemost. 2007;5(1):82-90.
36. Leithauser B, Zielske D, Seyfert UT, Jung F. Effects of desmopressin on platelet membrane glycoproteins and platelet aggregation in volunteers on clopidogrel. Clin Hemorheol Microcirc. 2008;39(1-4):293-302.
37. Vink R, van den Brink RB, Levi M. Management of anticoagulant therapy for patients with prosthetic heart valves or atrial fibrillation. Hematology. 2004;9(1):1-9.
38. Fernandez-Fernandez FJ, del Castillo-Fraile M. Acute abdominal pain in a patient receiving enoxaparin. Neth J Med. 2009;67(6):243-4.